Glucagon-like peptide-1 receptor agonist-related pancreatic neoplasms In five models, the PRR was greater than 2 for GLP-1RA-associated pancreatic neoplasms malignant (PRR for models 15: 22.16, 3.52, 2.78, 7.87, and 9.86) and ICN&AN (PRR for models 15: 4.36, 2.16, 2.12, 2.24, and 2.86)
The self-injectable drug semaglutide ( Ozempic ) was longer-acting than liraglutide
10.1093/nar/gkab951 Summary Keywords glutathione synthetase deficiency, 5-oxoprolinuria, glutathione synthetase gene variation, newborn, inherited metabolic disease, case report Citation Wu X, Jiao J, Xia Y, Yan X, Liu Z, Cao Y and Ma L (2023) Case report: A Chinese patient with glutathione synthetase deficiency and a novel glutathione synthase mutation
M.WuH.PageC.VoeltzG
GPX3 exhibits its activity within the cytoplasmic lysosomes and plasma membranes of mammalian cells located in various organs such as the kidney, heart, lungs, liver, brain, adipose tissue, mammary glands and gastrointestinal tract (25)